OrthoBio Therapeutics
Vail, US · Delaware corporation
Founders & leadership
MP
Marc PrisantExecutive
PJ
Peter J. MillettNamed on SEC filing
Board
SS
Stanley ShumanBoard director
JH
Jessica HopfieldBoard director
LD
Lodewijk de VinkBoard director
WT
William T. EsreyBoard director
RH
Robert HuginBoard director
Reported raises · per SEC filings
Form D private placements$31.4M disclosed across 1 round · 2025
▶$31.4MraisedJul 2025 · 45 investors · BiotechnologyRule 506(b)
▶$31.4MraisedJul 2025 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jessica HopfieldDirector
- Stanley ShumanDirector
- Marc PrisantExecutive Officer
- Peter J. MillettExecutive Officer, Director
- Lodewijk de VinkDirector
- William T. EsreyDirector
- Robert HuginDirector
- Offering amount
- $31.4M
- Amount sold
- $31.4M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has OrthoBio Therapeutics raised?
- OrthoBio Therapeutics has disclosed $31.4M raised across 1 round.
- Where is OrthoBio Therapeutics headquartered?
- OrthoBio Therapeutics is headquartered in Vail, US.